Dr. Toney discusses the phenomenon of mass extinctions occuring over the history of life on our planet, and how it is believed we are currently in the sixth worldwide extinction. He speculates on its relevance in the context of human pathogens such as Clostridium difficile, multidrug resistant gram negative enteric bacteria, and on the persistance of gut microbiota. He closes by discussing potential future therapies for human diseases given the waning antimicrobial agent options we currently have to treat them.
Dr. Manuel Castro presents an update on the effects that climate change is having on infectious diseases as we approach the end of the second decade of the new millennium. He covers the impact that a warming climate is having on ecosystems that breed infectious pathogens as well as the vectors that carry them.
Dr. Quilitz discusses the risk factors behind neutropenic fever. He then discusses prominent bacterial, fungal, and viral pathogens which cause infections in the immunocompromised cancer patient. Lastly, he discusses antimicrobial options to prevent or treat opportunistic infections in these patients.
Dr. John Greene discusses different patterns of consolidation visible on lung imaging and the differential diagnosis for pneumonia in immunocompetent and immunocompromised patients. He reviews CT imaging for ground glass opacities, consolidation, nodular opacities, and nodular cavitary lesions on the lungs. He covers interstitial pulmonary fibrosis, pulmonary alveolar proteinosis, community acquired viral and bacterial pneumonia, fungal infections, and mycobacterial infections among others. He specifically discusses nocardia, mycobacterium avium complex and hypersensitivity pneumonitis. He then covers several cases studies and management strategies. His updated talk was originally presented in 2013.
Dr. Baluch introduces the audience to to concept of hematopoietic stem cell transplantation. She discusses the timeline for infections and the tools for their work-up, including antimicrobial drugs. She also reviews the current paradigm for the work-up of neutropenic fever, and the treatment of “common” ID issues. Lastly, she discusses useful infectious diseases resources for the clinician.